# Ingenus Pharmaceuticals GmbH – FDA Inspection, Oct 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-gmbh/8c8bead2-8a44-454f-86a5-e331f7849dd1
Source feed: FDA_Inspections

> FDA inspection 1034770 of Ingenus Pharmaceuticals GmbH, October 31, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1034770
- Company Name: Ingenus Pharmaceuticals GmbH
- Inspection Date: 2017-10-31
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1263921 - 2024-10-03
- FDA Inspection 1115845 - 2019-12-03
- [FDA Inspection 1074093 - 2018-12-11](https://www.keypedia.com/records/fda_inspections/ingenus-pharmaceuticals-gmbh/77f0d2b8-0f1b-47cc-a2e6-7b9415943972)
- FDA Inspection 905257 - 2014-11-04

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/samantha-j-bradley/ba45f64f-07a9-4933-833f-b9b339c57783)
- [Senior Regulatory Specialist](https://www.keypedia.com/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942)

Company: https://www.keypedia.com/companies/ingenus-pharmaceuticals-gmbh/2255ec6f-3349-4a71-be33-91a83420b530

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c